Related Experiment Video
Updated: Jun 22, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Intrinsic signaling pathways modulate targeted protein degradation
Yuki Mori1,2, Yoshino Akizuki1,2, Rikuto Honda1,2
1Laboratory of Protein Degradation, Institute for Advanced Life Sciences, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.
Abstract:
Targeted protein degradation is a groundbreaking modality in drug discovery; however, the regulatory mechanisms are still not fully understood. Here, we identify cellular signaling pathways that modulate the targeted degradation of the anticancer target BRD4 and related neosubstrates BRD2/3 and CDK9 induced by CRL2VHL- or CRL4CRBN -based PROTACs. The chemicals identified as degradation enhancers include inhibitors of cellular signaling pathways such as poly-ADP ribosylation (PARG inhibitor PDD00017273), unfolded protein response (PERK inhibitor GSK2606414), and protein stabilization (HSP90 inhibitor luminespib). Mechanistically, PARG inhibition promotes TRIP12-mediated K29/K48-linked branched ubiquitylation of BRD4 by facilitating chromatin dissociation of BRD4 and formation of the BRD4-PROTAC-CRL2VHL ternary complex; by contrast, HSP90 inhibition promotes BRD4 degradation after the ubiquitylation step. Consequently, these signal inhibitors sensitize cells to the PROTAC-induced apoptosis. These results suggest that various cell-intrinsic signaling pathways spontaneously counteract chemically induced target degradation at multiple steps, which could be liberated by specific inhibitors.
Insights
Targeted protein degradation can be enhanced by inhibiting cellular signaling pathways. Inhibitors of PARG, PERK, and HSP90 boost the degradation of cancer targets like BRD4, sensitizing cells to apoptosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Targeted protein degradation is a promising drug discovery approach.
- Regulatory mechanisms controlling targeted protein degradation are not fully understood.
Purpose of the Study:
- To identify cellular signaling pathways that modulate targeted protein degradation of BRD4 and related neosubstrates.
- To investigate the mechanisms by which signaling pathway inhibitors enhance PROTAC-mediated degradation.
Main Methods:
- Utilized Proteolysis-Targeting Chimeras (PROTACs) based on CRL2-VHL and CRL4-CRBN.
- Investigated the effects of inhibitors targeting poly-ADP ribosylation (PARG), unfolded protein response (PERK), and heat shock protein 90 (HSP90).
- Analyzed ubiquitylation patterns and ternary complex formation.
Main Results:
- PARG inhibition (PDD00017273) promotes BRD4 degradation by facilitating chromatin dissociation and enhancing ternary complex formation.
- HSP90 inhibition (luminespib) enhances BRD4 degradation post-ubiquitylation.
- PERK inhibition (GSK2606414) also enhances degradation.
- These signal inhibitors sensitized cells to PROTAC-induced apoptosis.
Conclusions:
- Cell-intrinsic signaling pathways can counteract chemically induced target degradation at multiple steps.
- Inhibitors of specific signaling pathways can overcome these counteracting mechanisms, enhancing targeted protein degradation.
- This study reveals a druggable strategy to potentiate PROTAC efficacy in cancer therapy.
More Related Videos
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Extrinsic Apoptotic Pathway

